Literature DB >> 12725704

Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor.

Garry M Steil1, Kerstin Rebrin, John Mastrototaro, Basem Bernaba, Mohammed F Saad.   

Abstract

Continuous glucose monitoring has the potential to improve glucose management and reduce the risk of hypoglycemia in individuals with diabetes. Accurate sensors may also allow the development of a closed-loop insulin delivery system. The purpose of this work was to determine the delay time associated with a subcutaneous glucose sensor during rapidly changing glucose excursions. Subcutaneous glucose sensors (Medtronic MiniMed, Inc., Northridge, CA) were inserted in five healthy men. After a 2-h stabilization period, a 3-h hyperglycemic (approximately 11 mM) clamp was performed followed by a 90-min period in which plasma glucose was allowed to decline to as low as 2.8 mM. Sensors were calibrated using two points (basal and hyperglycemia), and the calibrated sensor glucose measurements were compared with those from a reference analyzer (Beckman Instruments, Fullerton, CA). Response time was estimated from a first-order kinetic model. Plasma glucose levels, determined with the subcutaneous sensor, were highly correlated with those obtained with the reference glucose analyzer (r(2) = 0.91, p < 0.001; mean absolute difference of approximately 8%). The half-time for the sensor response was estimated to be 4.0 +/- 1.0 min. The subcutaneous glucose sensor has the potential to facilitate the detection of hypoglycemia and improve overall glycemic control when used in a real-time monitor. The rapid response should be sufficient to allow a fully automated closed-loop insulin delivery system to be developed based on the subcutaneous sensing site.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12725704     DOI: 10.1089/152091503763816436

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  27 in total

1.  Continuous glucose monitoring: real-time algorithms for calibration, filtering, and alarms.

Authors:  B Wayne Bequette
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

2.  Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus.

Authors:  Raymond J Davey; Timothy W Jones; Paul A Fournier
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

3.  Use of subcutaneous interstitial fluid glucose to estimate blood glucose: revisiting delay and sensor offset.

Authors:  Kerstin Rebrin; Norman F Sheppard; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

4.  Continuous glucose monitoring in subjects with type 1 diabetes: improvement in accuracy by correcting for background current.

Authors:  Joseph El Youssef; Jessica R Castle; Julia M Engle; Ryan G Massoud; W Kenneth Ward
Journal:  Diabetes Technol Ther       Date:  2010-09-30       Impact factor: 6.118

5.  Glycaemic control is improved by 7 days of aerobic exercise training in patients with type 2 diabetes.

Authors:  C R Mikus; D J Oberlin; J Libla; L J Boyle; J P Thyfault
Journal:  Diabetologia       Date:  2012-02-04       Impact factor: 10.122

6.  Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring.

Authors:  Ulrike Holzinger; Joanna Warszawska; Reinhard Kitzberger; Harald Herkner; Philipp G H Metnitz; Christian Madl
Journal:  Intensive Care Med       Date:  2009-04-07       Impact factor: 17.440

7.  Real-time continuous glucose monitoring in the clinical setting: the good, the bad, and the practical.

Authors:  Irene Mamkin; Svetlana Ten; Sonal Bhandari; Neesha Ramchandani
Journal:  J Diabetes Sci Technol       Date:  2008-09

8.  Recent advances in continuous glucose monitoring: biocompatibility of glucose sensors for implantation in subcutis.

Authors:  Peter H Kvist; Henrik E Jensen
Journal:  J Diabetes Sci Technol       Date:  2007-09

9.  Combined insulin pump therapy with real-time continuous glucose monitoring significantly improves glycemic control compared to multiple daily injection therapy in pump naïve patients with type 1 diabetes; single center pilot study experience.

Authors:  Scott W Lee; Tom Sweeney; Debbie Clausen; Celia Kolbach; Allen Hassen; Anthony Firek; Charles Brinegar; Jerrold Petrofsky
Journal:  J Diabetes Sci Technol       Date:  2007-05

10.  Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial.

Authors:  Ulrike Holzinger; Joanna Warszawska; Reinhard Kitzberger; Marlene Wewalka; Wolfgang Miehsler; Harald Herkner; Christian Madl
Journal:  Diabetes Care       Date:  2009-12-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.